Pneumonia Testing Market 2022 | Asia-Pacific is expected to register the fastest CAGR during the forecast period

Pneumonia is a type of lung infection caused by bacteria, such as the Streptococcus pneumonia virus, fungi, and parasites. In pneumonia, the air sacs of the lungs called alveoli are filled with fluid or pus that causes inflammation. The symptoms of pneumonia include short breathing, fever, chest pain, nausea & vomiting. However, these clinical symptoms overlap with many other diseases, such as asthma, bronchitis, and the common cold, making it difficult to diagnose pneumonia. Physicians recommend tests such as blood tests, sputum tests, pleural fluid cultures, and pulse oximetry tests to confirm the onset of pneumonia.

Do Enquiry for Sample Report @ https://www.alliedmarketresearch.com/request-sample/3776

KEY FINDINGS OF THE STUDY

By the method, the point of care test was the highest contributor to the market in 2020.
By technology, the enzyme-linked immunosorbent assay (ELISA) was the highest contributor to the Pneumonia Testing Industry in 2020.
By type, the analyzers were the highest contributor to the market in 2020.
By end-user, the hospitals were the highest contributor to the market in 2020.
Region-wise, North America garnered the largest revenue share in 2020; however, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
The Pneumonia Testing Industry is segmented on the basis of method, technology, type & end-user region. In terms of method, it is classified into immunodiagnostics, molecular diagnostics, and point-of-care (POC) testing. By type, it is bifurcated into analyzers and consumables. Based on technology, it is categorized into enzyme-linked immunosorbent assay (ELISA), immunofluorescence, western blot, polymerase chain reaction (PCR), immunohistochemistry (IHC), and others. Depending on the end-user, it is classified into hospitals, diagnostic laboratories, home care, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The POC testing segment was the major contributor to the market in 2020, due to multiple benefits offered by this technique, such as technological advancements, ease of use, and rapid results. The analyzers segment is estimated to register the highest growth rate during the forecast period, owing to t their frequent usage for pneumonia tests from 2020-to 2030.

Polymerase chain reaction registered the highest growth rate in the forecast period among the different technologies, as this test can identify the causative agent and accurately detect pneumonia in patients. Among the end-user, the hospital occupied the major share of the pneumonia testing market in 2021, due to a large number of patients suffering from pneumonia across the world.

Key Market Players

Abott Laboratories
F.hoffman La roche
Thermofischer Inc
Hologic Inc
Biomerieux SA
Quidel Corporation
Bio Rad laborateries
Beckton and Dickinson Company
AdvanDx
Beckman Coulter

Region-wise the Pneumonia Testing Market Analysis is done across North America, Europe, Asia-Pacific, and LAMEA, in 2020, North America accounted for the maximum Pneumonia Testing Market Share in 2020, owing to the rise in prevalence of pneumonia and a surge in technological advancements in various pneumonia testing products. However, Asia-Pacific is projected to grow at the highest CAGR during the forecast period, owing to an increase in investments by major companies in R&D activities.

Key Market Segments

By Types
ConsumablesX`
Analyzers
By Method
Molecular Diagnostics
Point of Care Testing
Immunodiagnostics
By Technology
Enzyme Linked Immunosorbant Assay
Immunofluoroscence
Western Blot
Polymerase Chain Reaction
Imunohistochemistry
Others

Get Customized Report @ https://www.alliedmarketresearch.com/request-for-customization/3776